$1.28
-0.01-0.78%
At close: May 14, 5:00 PM EST
$1.28
N/A
After Hours: 8:05 AM EST
Actinium Pharmaceuticals Inc Earnings Estimates
ATNMAMEX
Earnings: Q1 2026 Earnings were released on Fri May 8th, after the market close
Actinium Pharmaceuticals Earnings Estimates, EPS & Revenue | AMEX:ATNM
Actinium Pharmaceuticals (ATNM) is scheduled to report Q2 earnings on August 7, 2026. Analysts estimate EPS of $-0.20 and quarterly revenue of N/A.
In the most recent quarter (Q1), Actinium Pharmaceuticals reported EPS of $-0.18, beating estimates of $-0.22 by 0.18%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Actinium Pharmaceuticals has beaten EPS estimates in 4 consecutive quarters.
Over the last 4 quarters, Actinium Pharmaceuticals has averaged an EPS surprise of 0.22% and a revenue surprise of 0.00%.
Earnings Date
Aug 7
EPS Estimate
$-0.200
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$90.00K
Actinium Pharmaceuticals Earnings History
Analyze the earnings history of Actinium Pharmaceuticals using advanced sorting and filters.
Loading calendar...
Actinium Pharmaceuticals (ATNM) Earnings Per Share
The chart below shows Actinium Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
Actinium Pharmaceuticals (ATNM) Revenue
The chart below shows Actinium Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Actinium Pharmaceuticals (AMEX:ATNM) reporting earnings?
Actinium Pharmaceuticals (ATNM) is scheduled to report earnings on August 7, 2026. The last reported earnings were for reported on May 8, 2026 for Q1.
What were the latest earnings per share (EPS) for Actinium Pharmaceuticals (AMEX:ATNM)?
The Actual EPS was $-0.18, which beat the estimate of $-0.22.
What were Actinium Pharmaceuticals’s (AMEX:ATNM) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
